• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性疾病中的免疫复合物。

Immune complexes in myeloproliferative disorders.

作者信息

Lewis C M, Pegrum G D

出版信息

Lancet. 1977 Dec 3;2(8049):1151-3. doi: 10.1016/s0140-6736(77)91539-2.

DOI:10.1016/s0140-6736(77)91539-2
PMID:73061
Abstract

A fluorescein-labelled anti-human immunoglobulin was used to demonstrate that peripheral blood from patients with myelofibrosis had a high proportion of phagocytic cells containing fluorescent immune complexes. Cells from patients with other myeloproliferative diseases (either chronic myeloid leukaemia or polycythaemia rubra vera) did not show similar intracellular immune complexes. Serum from patients with myelofibrosis incubated with polymorphs from healthy subjects caused the appearance of inclusions similar to those found when the patients' own cells were used, the healthy phagocytes apparently engulfing complexes from the patients' sera. The presence of platelets or complement did not alter the incidence of intracellular fluorescence. These tests may help in the diagnosis of myelofibrosis and may also be valuable in recognising the onset of this condition in patients with polycythaemia rubra vera.

摘要

使用荧光素标记的抗人免疫球蛋白来证明,骨髓纤维化患者的外周血中有高比例的吞噬细胞含有荧光免疫复合物。患有其他骨髓增殖性疾病(慢性粒细胞白血病或真性红细胞增多症)的患者细胞未显示出类似的细胞内免疫复合物。骨髓纤维化患者的血清与健康受试者的多形核白细胞孵育后,会出现与使用患者自身细胞时发现的类似包涵体,健康的吞噬细胞显然吞噬了患者血清中的复合物。血小板或补体的存在并未改变细胞内荧光的发生率。这些检测可能有助于骨髓纤维化的诊断,在识别真性红细胞增多症患者中这种疾病的发作方面也可能有价值。

相似文献

1
Immune complexes in myeloproliferative disorders.骨髓增殖性疾病中的免疫复合物。
Lancet. 1977 Dec 3;2(8049):1151-3. doi: 10.1016/s0140-6736(77)91539-2.
2
[Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].[淋巴增殖性疾病和骨髓增殖性疾病患者的循环免疫复合物]
Quad Sclavo Diagn. 1984 Jun;20(2):193-202.
3
Increased circulating neutrophils with surface receptor activity for immunoglobulin G in polycythemia vera and myeloid metaplasia.
Blood. 1979 Jun;53(6):1106-13.
4
Phagocytosis in myeloproliferative disorders.
Am J Clin Pathol. 1980 Sep;74(3):301-5. doi: 10.1093/ajcp/74.3.301.
5
[Criteria of differential diagnosis of chronic myeloproliferative diseases].[慢性骨髓增殖性疾病的鉴别诊断标准]
Gematol Transfuziol. 1991 Jun;36(6):3-4.
6
[Serum immunological abnormalities in myeloid splenomegaly and myelosclerosis].[骨髓性脾肿大和骨髓硬化症中的血清免疫异常]
Rev Roum Med Intern. 1973;10(3):170-7.
7
Immunologic dysfunction in the myeloproliferative disorders.骨髓增殖性疾病中的免疫功能障碍。
Cancer. 1978 Jul;42(1):149-58. doi: 10.1002/1097-0142(197807)42:1<149::aid-cncr2820420125>3.0.co;2-i.
8
Platelet factor VIII-related antigen in patients with chronic myeloproliferative disorders.
Thromb Res. 1980 Aug 1;19(3):423-7. doi: 10.1016/0049-3848(80)90271-6.
9
Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.骨髓增殖性疾病中循环的高分子量IgG纤连蛋白复合物
J Clin Pathol. 1990 Feb;43(2):102-5. doi: 10.1136/jcp.43.2.102.
10
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.慢性骨髓增殖性疾病中骨髓单核细胞祖细胞(CFU-GM)的抗原表型
Cancer Res. 1986 Feb;46(2):975-80.

引用本文的文献

1
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.靶向代谢组学揭示原发性骨髓纤维化患者血清中抗氧化剂显著消耗、氧化/亚硝化应激增加以及嘌呤和嘧啶浓度改变。
Antioxidants (Basel). 2024 Apr 19;13(4):490. doi: 10.3390/antiox13040490.
2
Clonal haematopoiesis and dysregulation of the immune system.克隆性造血与免疫系统失调。
Nat Rev Immunol. 2023 Sep;23(9):595-610. doi: 10.1038/s41577-023-00843-3. Epub 2023 Mar 20.
3
Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation.
通过综合生物信息学分析和临床验证鉴定原发性血小板增多症中的潜在关键基因和调控标志物
Pharmgenomics Pers Med. 2021 Jul 5;14:767-784. doi: 10.2147/PGPM.S309166. eCollection 2021.
4
Immune Complex Associated Glomerulonephritis in a Patient with Prefibrotic Primary Myelofibrosis: A Case Report.纤维化前原发性骨髓纤维化患者的免疫复合物相关性肾小球肾炎:一例报告
Indian J Nephrol. 2021 Jan-Feb;31(1):50-53. doi: 10.4103/ijn.IJN_222_19. Epub 2021 Jan 27.
5
Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.骨髓纤维化患者的免疫紊乱:调节性T细胞、辅助性T细胞17和可溶性白细胞介素2受体α的作用
PLoS One. 2015 Mar 20;10(3):e0116723. doi: 10.1371/journal.pone.0116723. eCollection 2015.
6
Familial cutaneous vasculopathy of German shepherds: clinical, genetic and preliminary pathological and immunological studies.德国牧羊犬家族性皮肤血管病:临床、遗传及初步病理和免疫学研究
Can Vet J. 1994 Dec;35(12):763-9.
7
How should we manage myelofibrosis?我们应该如何治疗骨髓纤维化?
J R Coll Physicians Lond. 1981 Jan;15(1):17-8.
8
Platelet Fc receptor. Increased expression in myeloproliferative disease.血小板Fc受体。在骨髓增殖性疾病中表达增加。
J Clin Invest. 1981 Apr;67(4):1064-71. doi: 10.1172/jci110118.